ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) will participate in two upcoming healthcare conferences: Truist Securities BioPharma Symposium on November 9, 2023, and Jefferies London Healthcare Conference on November 15, 2023. The company's CEO and CFO will be attending and available for 1x1 meetings. The webcast of the conferences will be accessible on the company's website.
10/30/2023 - 06:50 AM
BAUDETTE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences as follows:
Truist Securities BioPharma Symposium (1x1s Only)
Date: Thursday, November 9, 2023
To schedule a 1x1 meeting with management, please contact Angela.Mouta@truist.com .
Jefferies London Healthcare Conference
Date: Wednesday, November 15, 2023 Time: 10:00am ET / 3:00pm GMT Webcast: Click here
To schedule a 1x1 meeting with the Company, for November 14 or November 15, please contact Isabel Zakoscielny IZakoscielny@Jefferies.com.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com .
Investor Relations: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
Which healthcare conferences will ANI Pharmaceuticals participate in?
ANI Pharmaceuticals will participate in the Truist Securities BioPharma Symposium and Jefferies London Healthcare Conference.
When will the Truist Securities BioPharma Symposium take place?
The Truist Securities BioPharma Symposium will take place on Thursday, November 9, 2023.
How can I schedule a 1x1 meeting with ANI Pharmaceuticals' management?
To schedule a 1x1 meeting with ANI Pharmaceuticals' management, please contact Angela.Mouta@truist.com for the Truist Securities BioPharma Symposium, and Isabel Zakoscielny IZakoscielny@Jefferies.com for the Jefferies London Healthcare Conference.
Where can I access the webcast of the conferences?
The webcast of the conferences will be accessible on ANI Pharmaceuticals' website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations.
How long will the webcast replay be accessible?
The webcast replay will be accessible for 90 days.
ANIP Rankings
#367 Ranked by Stock Gains
ANIP Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Baudette
About ANIP
ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
